WebDec 4, 2024 · Dr. Greg Fahy gives an update on the TRIIM-X clinical trial at EARD 2024. The TRIIM-X clinical trial aims to understand how to create a personalized thymus regeneration regimen. By regenerating the thymus, the researchers hope to be able to prevent or reverse certain aspects of immune system aging. FOLLOW US. WebAug 6, 2024 · Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr.
Greg Fahy on the TRIIM-X Trial, Human Growth Hormone …
WebSep 6, 2024 · Regenerating the thymus could be a major breakthrough for combating the diseases of aging and helping people with weak immune systems, such as older people who often fall prey to infectious diseases … WebWatched a video of Greg Fahy on Modern Lifespan YouTube channel . He appears to be much younger than previous images and he has been doing his HGH protocol since … high school makeup tumblr
First hint that body’s ‘biological age’ can be reversed
WebMagnetic resonance imaging was used to detect signs of regeneration of the thymus after approximately one month of human growth hormone administration. A 46-year-old … WebJan 5, 2024 · The TRIIM-X trial is an expanded pilot clinical study that will evaluate a personalized combination treatment regimen for thymus regeneration. The thymus is a part of the immune system that declines markedly with age, and regenerating it may prevent or reverse key aspects of immunosenescence (immune system aging) and potentially … WebGreg Fahy, PhD, Chief Scientific Officer, Co-founder-Designed and led the TRIIM trial; Published the first report of thymus regeneration in a normal human; Granted patents on methods for and applications of human thymus regeneration –Fellow of the American Aging Association (since 2005), Former Director of the American Aging Association (16 ... high school male hairstyles